H1B Salary Data

Home › Employers › Ipca Pharmaceuticals Inc

Ipca Pharmaceuticals Inc: H-1B salaries and sponsorship

Ipca Pharmaceuticals Inc filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $224,000.

Applications (LCAs)3
Certified3
Employer addressEast Brunswick, NJ
H-1B dependent employerNo
Median offered salary$224,000
Middle half of salaries$178,000–$224,000
10th–90th percentile$150,400–$224,000

Does Ipca Pharmaceuticals Inc sponsor H-1B visas?

Ipca Pharmaceuticals Inc filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 29, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Associate Vice President2$224,000
Director, Business Development1$132,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$132,000
FY20262$224,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Associate Vice President$224,000
Level III
East Brunswick, NJApr 29, 2026Oct 29, 2026Certified
Associate Vice President$224,000
Level III
East Brunswick, NJMar 3, 2026Jun 14, 2026Certified
Director, Business Development$132,000
Level IV
South Plainfield, NJFeb 27, 2023Aug 25, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).